Catalyst Pharmaceuticals Ownership | Who Owns Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals Ownership Summary
Catalyst Pharmaceuticals is owned by 84.46% institutional investors, 6.32% insiders, and 9.21% retail investors. Blackrock is the largest institutional shareholder, holding 16.01% of CPRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.57% of its assets in Catalyst Pharmaceuticals shares.
CPRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Catalyst Pharmaceuticals | 84.46% | 6.32% | 9.21% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 18.69M | 16.01% | $289.58M |
| Blackrock funding, inc. /de | 18.22M | 14.91% | $358.86M |
| Vanguard group | 8.71M | 7.13% | $171.66M |
| State street | 6.41M | 5.24% | $126.19M |
| Deerfield management company, l.p. (series c) | 4.97M | 4.07% | $98.00M |
| Renaissance | 3.54M | 2.90% | $69.83M |
| Fundsmith llp | 3.36M | 2.75% | $66.27M |
| Geode capital management | 2.89M | 2.37% | $56.95M |
| American century companies | 2.53M | 2.07% | $49.81M |
| Dimensional fund advisors lp | 2.46M | 2.01% | $48.42M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tanaka capital management | 114.42K | 4.06% | $2.25M |
| Gables capital management | 435.42K | 3.68% | $8.58M |
| Jw asset management | 388.39K | 3.67% | $7.65M |
| Knott david m jr | 189.00K | 1.50% | $3.72M |
| Deerfield management company, l.p. (series c) | 4.97M | 1.50% | $98.00M |
| Mesirow institutional investment management | 742.29K | 1.19% | $15.49M |
| Qsv equity investors | 53.49K | 1.08% | $1.05M |
| Bridge city capital | 182.30K | 0.96% | $3.59M |
| Globeflex capital l p | 290.68K | 0.88% | $5.73M |
| Pvg asset management | 11.79K | 0.72% | $182.56K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 4.97M | 1.50% | 2.10M |
| Blackrock | 18.69M | 0.01% | 962.28K |
| State street | 6.41M | 0.00% | 927.00K |
| American century companies | 2.53M | 0.03% | 770.20K |
| Fundsmith llp | 3.36M | 0.33% | 654.72K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 1.01M | 0.00% | -1.40M |
| Morgan stanley | 1.84M | 0.00% | -1.34M |
| Blackrock funding, inc. /de | 18.22M | 0.01% | -684.38K |
| Point72 asset management | - | - | -618.30K |
| Nuveen | 542.23K | 0.00% | -444.04K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Eversept partners, lp | 350.81K | 0.48% | 350.81K | $6.91M |
| Brandywine global investment management | 310.99K | 0.04% | 310.99K | $6.13M |
| Alyeska investment group | 273.29K | 0.02% | 273.29K | $5.38M |
| Wedge capital management l l p/nc | 145.17K | 0.05% | 145.17K | $2.86M |
| Tanaka capital management | 114.42K | 4.06% | 114.42K | $2.25M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -1.00 |
| Coppell advisory solutions | -8.00 |
| Mendota financial group | -12.00 |
| Strengthening families & communities | -15.00 |
| Richards, merrill & peterson | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 351 | -3.57% | 103,180,919 | 1.77% | 84 | 1.23% | 169 | -19.52% | 129 | 5.74% |
| Jun 30, 2025 | 354 | -3.54% | 101,094,756 | 3.01% | 82 | 1.27% | 204 | 3.55% | 118 | -2.48% |
| Mar 31, 2025 | 361 | 6.80% | 97,419,101 | -0.16% | 80 | 1.19% | 193 | -4.46% | 119 | 33.71% |
| Dec 31, 2024 | 329 | 4.44% | 99,023,975 | 3.92% | 83 | 1.30% | 195 | 21.88% | 87 | -17.14% |
| Sep 30, 2024 | 313 | 14.65% | 95,228,606 | -1.82% | 80 | 1.16% | 159 | 25.20% | 104 | 18.18% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.82M | 5.57% | - |
| Vanguard Total Stock Mkt Idx Inv | 3.63M | 2.97% | -77.47K |
| Vanguard US Total Market Shares ETF | 3.55M | 2.91% | 3.78K |
| iShares Russell 2000 ETF | 2.78M | 2.27% | - |
| Smithson Investment Trust Ord | 2.71M | 2.21% | - |
| First Trust NYSE Arca Biotech ETF | 1.89M | 1.59% | - |
| Avantis US Small Cap Value ETF | 1.80M | 1.47% | 14.54K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.23M | 1.01% | -534.49K |
| SPDR® S&P Biotech ETF | 1.17M | 0.95% | 2.60K |
| Fidelity Small Cap Index | 1.16M | 0.95% | 15.51K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 26, 2025 | Del Carmen Jeffrey | Chief Commercial Officer | Sell | $256.24K |
| Nov 12, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Buy | $908.00K |
| Sep 08, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $609.00K |
| Sep 04, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $585.60K |
| Sep 03, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $401.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 5 |
| 2024 Q4 | - | 14 |
CPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools